Assam gets NMC approval for new medical college in Dhubri

Published On 2022-08-09 04:30 GMT   |   Update On 2022-08-09 04:30 GMT

Guwahati: The National Medical Commission (NMC) on Monday approved a new medical college at Dhubri in Assam, making it the ninth such institute in this North Eastern state. Approval has been granted for starting the MBBS course with an intake of 100 students annually from the academic year 2022-23, a letter from the NCM, Medical Assessment & Rating Board (MARB), Undergraduate...

Login or Register to read the full article

Guwahati: The National Medical Commission (NMC) on Monday approved a new medical college at Dhubri in Assam, making it the ninth such institute in this North Eastern state.

Approval has been granted for starting the MBBS course with an intake of 100 students annually from the academic year 2022-23, a letter from the NCM, Medical Assessment & Rating Board (MARB), Undergraduate Section, said.

The letter addressed to the dean/principal of the new college, said the MARB examined the assessor's report and remarks of the UG expert group on infrastructure facilities, availability of faculty and other facilities.

The Board also reviewed clarifications on the deficiencies through virtual hearing, and following it, approval has been given for intake of 100 MBBS students annually from the academic year 2022-23.

Sharing the NCM letter on Twitter, Chief Minister Himanta Biswa Sarma wrote: Glad to share that the MBBS course of new Dhubri Medical College (9th medical college of Assam) under Srimanta Sankardeva University of Health Sciences with 100 seats has received the approval of Medical Assessment & Rating Board under the National Medical Commission.

Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News